Spatiotemporal material functionalization via competitive supramolecular complexation of avidin and biotin analogs.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
25 09 2019
Historique:
received: 14 11 2018
accepted: 05 09 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 14 1 2020
Statut: epublish

Résumé

Spatiotemporal control over engineered tissues is highly desirable for various biomedical applications as it emulates the dynamic behavior of natural tissues. Current spatiotemporal biomaterial functionalization approaches are based on cytotoxic, technically challenging, or non-scalable chemistries, which has hampered their widespread usage. Here we report a strategy to spatiotemporally functionalize (bio)materials based on competitive supramolecular complexation of avidin and biotin analogs. Specifically, an injectable hydrogel is orthogonally post-functionalized with desthiobiotinylated moieties using multivalent neutravidin. In situ exchange of desthiobiotin by biotin enables spatiotemporal material functionalization as demonstrated by the formation of long-range, conformal, and contra-directional biochemical gradients within complex-shaped 3D hydrogels. Temporal control over engineered tissue biochemistry is further demonstrated by timed presentation and sequestration of growth factors using desthiobiotinylated antibodies. The method's universality is confirmed by modifying hydrogels with biotinylated fluorophores, peptides, nanoparticles, enzymes, and antibodies. Overall, this work provides a facile, cytocompatible, and universal strategy to spatiotemporally functionalize materials.

Identifiants

pubmed: 31554812
doi: 10.1038/s41467-019-12390-4
pii: 10.1038/s41467-019-12390-4
pmc: PMC6761202
doi:

Substances chimiques

Antibodies 0
Biocompatible Materials 0
Hydrogels 0
Macromolecular Substances 0
Peptides 0
Avidin 1405-69-2
Biotin 6SO6U10H04

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4347

Références

J Am Chem Soc. 2010 Oct 6;132(39):13630-2
pubmed: 20839864
Nat Mater. 2015 Mar;14(3):352-60
pubmed: 25502097
BMC Cell Biol. 2007 Sep 19;8:41
pubmed: 17880711
Anal Chem. 2009 Jan 1;81(1):336-42
pubmed: 19117461
Chem Commun (Camb). 2013 May 18;49(40):4504-6
pubmed: 23572056
Biomaterials. 2005 Feb;26(4):359-71
pubmed: 15275810
Nat Mater. 2009 Aug;8(8):659-64
pubmed: 19543279
Nat Mater. 2011 Oct;10(10):799-806
pubmed: 21874004
Angew Chem Int Ed Engl. 2013 Nov 11;52(46):12077-80
pubmed: 24108659
J Biomech. 2010 Jan 5;43(1):146-55
pubmed: 19800625
Int J Mol Sci. 2015 Jul 14;16(7):15997-6016
pubmed: 26184185
Anal Chem. 2008 Sep 15;80(18):7063-7
pubmed: 18712935
Dev Cell. 2002 Jun;2(6):785-96
pubmed: 12062090
Biomaterials. 2013 Dec;34(38):9969-79
pubmed: 24060418
Cell. 1996 Nov 29;87(5):833-44
pubmed: 8945511
Angew Chem Int Ed Engl. 2015 May 11;54(20):5957-61
pubmed: 25808026
J Vis Exp. 2018 Apr 25;(134):
pubmed: 29757292
Biotechnology (N Y). 1990 Sep;8(9):854-6
pubmed: 1366797
J Cell Sci. 2008 Feb 1;121(Pt 3):255-64
pubmed: 18216330
Chem Soc Rev. 2017 Oct 30;46(21):6532-6552
pubmed: 28820527
Biomaterials. 2010 Nov;31(32):8228-34
pubmed: 20674004
Nat Commun. 2012 Apr 24;3:792
pubmed: 22531177
Adv Mater. 2014 Apr 23;26(16):2521-6
pubmed: 24523204
J Mater Chem B. 2016 Aug 7;4(29):4969-4974
pubmed: 32264023
Annu Rev Biochem. 2013;82:775-97
pubmed: 23495938
J Biomed Mater Res. 2000 Jun 5;50(3):397-404
pubmed: 10737882
Anal Chem. 2011 Mar 15;83(6):2005-11
pubmed: 21291180
PLoS One. 2019 Feb 28;14(2):e0204194
pubmed: 30818336
Methods Enzymol. 1990;184:14-45
pubmed: 2201873
Tissue Eng Part A. 2010 Aug;16(8):2429-40
pubmed: 20214454
Biomaterials. 2001 Jun;22(11):1197-203
pubmed: 11336291
J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200
pubmed: 21123617
Biochem J. 1987 Nov 15;248(1):167-71
pubmed: 3435435
ACS Appl Mater Interfaces. 2018 Apr 18;10(15):12374-12389
pubmed: 29537822
Nat Rev Mol Cell Biol. 2009 Jan;10(1):34-43
pubmed: 19197330
Anal Biochem. 2002 Sep 15;308(2):343-57
pubmed: 12419349
J Am Chem Soc. 2012 Sep 26;134(38):15716-9
pubmed: 22970862
Adv Protein Chem. 1975;29:85-133
pubmed: 237414
Nat Mater. 2018 Aug;17(8):732-739
pubmed: 29867165

Auteurs

Tom Kamperman (T)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. t.kamperman@utwente.nl.

Michelle Koerselman (M)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

Cindy Kelder (C)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

Jan Hendriks (J)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

João F Crispim (JF)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

Xandra de Peuter (X)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

Pieter J Dijkstra (PJ)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

Marcel Karperien (M)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands.

Jeroen Leijten (J)

Faculty of Science and Technology, Technical Medical Centre, Department of Developmental BioEngineering, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. jeroen.leijten@utwente.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH